Bionano Genomics to Present at the 2022 H.C. Wainwright Global Investment Conference
May 17 2022 - 4:05PM
Bionano Genomics, Inc. (BNGO), pioneer of optical genome mapping
(OGM) solutions on the Saphyr® system and provider of NxClinical™
software, the leading solution for visualization, interpretation
and reporting of genomic data, today announced its virtual
participation in the 2022 H.C. Wainwright Global Investment
Conference. Erik Holmlin, PhD, Bionano’s president and chief
executive officer, will present a company overview available
for on-demand listening starting Tuesday, May 24, 2022, at 7:00
a.m. Eastern Time. Interested parties can register for the
conference and view the presentation
here: www.hcwevents.com/globalconference.
About Bionano Genomics Bionano Genomics is a
provider of genome analysis solutions that can enable researchers
and clinicians to reveal answers to challenging questions in
biology and medicine. The Company’s mission is to transform the way
the world sees the genome through OGM solutions, diagnostic
services and software. The Company offers OGM solutions for
applications across basic, translational and clinical research.
Through its Lineagen business, the Company also provides diagnostic
testing for patients with clinical presentations consistent with
autism spectrum disorder and other neurodevelopmental disabilities.
Through its BioDiscovery business, the Company also offers an
industry-leading, platform-agnostic software solution, which
integrates next-generation sequencing and microarray data designed
to provide analysis, visualization, interpretation and reporting of
copy number variants, single-nucleotide variants and absence of
heterozygosity across the genome in one consolidated view. For more
information, visit bionanogenomics.com, lineagen.com or
biodiscovery.com.
CONTACTS Company Contact: Erik Holmlin, CEO
Bionano Genomics, Inc. +1 (858) 888-7610
eholmlin@bionanogenomics.com
Investor Relations: Amy Conrad Juniper Point +1 (858) 366-3243
amy@juniper-point.com
Bionano Genomics (NASDAQ:BNGO)
Historical Stock Chart
From Aug 2024 to Sep 2024
Bionano Genomics (NASDAQ:BNGO)
Historical Stock Chart
From Sep 2023 to Sep 2024